These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26567133)

  • 21. Through the looking glass, mechanistic insights from enantiomeric human defensins.
    Wei G; de Leeuw E; Pazgier M; Yuan W; Zou G; Wang J; Ericksen B; Lu WY; Lehrer RI; Lu W
    J Biol Chem; 2009 Oct; 284(42):29180-92. PubMed ID: 19640840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human beta-defensins 1-3.
    Krishnakumari V; Singh S; Nagaraj R
    Peptides; 2006 Nov; 27(11):2607-13. PubMed ID: 16860904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.
    Wang C; Zhao G; Wang S; Chen Y; Gong Y; Chen S; Xu Y; Hu M; Wang X; Zeng H; Wang A; Liu D; Su Y; Cheng T; Chen F; Wang J
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibacterial activities and conformations of synthetic alpha-defensin HNP-1 and analogs with one, two and three disulfide bridges.
    Mandal M; Nagaraj R
    J Pept Res; 2002 Mar; 59(3):95-104. PubMed ID: 11985703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability.
    Rajabi M; de Leeuw E; Pazgier M; Li J; Lubkowski J; Lu W
    J Biol Chem; 2008 Aug; 283(31):21509-18. PubMed ID: 18499668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and characterization of a disulfide-locked C(2)-symmetric defensin peptide.
    Wommack AJ; Ziarek JJ; Tomaras J; Chileveru HR; Zhang Y; Wagner G; Nolan EM
    J Am Chem Soc; 2014 Oct; 136(39):13494-7. PubMed ID: 25181039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins.
    Seo EJ; Weibel S; Wehkamp J; Oelschlaeger TA
    Int J Med Microbiol; 2012 Nov; 302(6):276-87. PubMed ID: 22748509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical determinants of human α-defensin 5 activity against non-enveloped viruses.
    Gounder AP; Wiens ME; Wilson SS; Lu W; Smith JG
    J Biol Chem; 2012 Jul; 287(29):24554-62. PubMed ID: 22637473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of human defensin 5 (HD5) self-assembly in solution: Molecular simulations/insights.
    Chairatana P; Niramitranon J; Pongprayoon P
    Comput Biol Chem; 2019 Dec; 83():107091. PubMed ID: 31349122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delineation of interfaces on human alpha-defensins critical for human adenovirus and human papillomavirus inhibition.
    Tenge VR; Gounder AP; Wiens ME; Lu W; Smith JG
    PLoS Pathog; 2014 Sep; 10(9):e1004360. PubMed ID: 25188351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction Impairs the Antibacterial Activity but Benefits the LPS Neutralization Ability of Human Enteric Defensin 5.
    Wang C; Shen M; Zhang N; Wang S; Xu Y; Chen S; Chen F; Yang K; He T; Wang A; Su Y; Cheng T; Zhao J; Wang J
    Sci Rep; 2016 Mar; 6():22875. PubMed ID: 26960718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analysis of the alpha-defensin disulfide array in mouse cryptdin-4.
    Maemoto A; Qu X; Rosengren KJ; Tanabe H; Henschen-Edman A; Craik DJ; Ouellette AJ
    J Biol Chem; 2004 Oct; 279(42):44188-96. PubMed ID: 15297466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Succinylated casein-coated peptide-mesoporous silica nanoparticles as an antibiotic against intestinal bacterial infection.
    Zhao G; Chen Y; He Y; Chen F; Gong Y; Chen S; Xu Y; Su Y; Wang C; Wang J
    Biomater Sci; 2019 May; 7(6):2440-2451. PubMed ID: 30939184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of increasing hydrophobicity by N-terminal myristoylation on the antibacterial and hemolytic activities of the C-terminal cationic segments of human-β-defensins 1-3.
    Krishnakumari V; Guru A; Adicherla H; Nagaraj R
    Chem Biol Drug Des; 2018 Aug; 92(2):1504-1513. PubMed ID: 29682907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity of truncated alpha-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges.
    Lundy FT; Nelson J; Lockhart D; Greer B; Harriott P; Marley JJ
    Mol Immunol; 2008 Jan; 45(1):190-3. PubMed ID: 17548109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A study of human beta-defensin-1 and human beta-defensin-2 in airway mucosal defense].
    Hiratsuka T; Nakazato M; Ashitani J; Matsukura S
    Kansenshogaku Zasshi; 1999 Feb; 73(2):156-62. PubMed ID: 10213993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines.
    Varkey J; Nagaraj R
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4561-6. PubMed ID: 16251296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The adsorption of human defensin 5 on bacterial membranes: simulation studies.
    Awang T; Pongprayoon P
    J Mol Model; 2018 Sep; 24(10):273. PubMed ID: 30187138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The penetration of human defensin 5 (HD5) through bacterial outer membrane: simulation studies.
    Awang T; Pongprayoon P
    J Mol Model; 2021 Sep; 27(10):291. PubMed ID: 34546425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and antimicrobial activity of platypus 'intermediate' defensin-like peptide.
    Torres AM; Bansal P; Koh JM; Pagès G; Wu MJ; Kuchel PW
    FEBS Lett; 2014 May; 588(9):1821-6. PubMed ID: 24694388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.